Last Updated: November 8, 2026

CITANEST PLAIN Drug Patent Profile

Name: CITANEST PLAIN Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

When do Citanest Plain patents expire, and when can generic versions of Citanest Plain launch?

Citanest Plain is a drug marketed by Astrazeneca and Dentsply Pharm and is included in two NDAs.

The generic ingredient in CITANEST PLAIN is prilocaine hydrochloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the prilocaine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Citanest Plain

A generic version of CITANEST PLAIN was approved as prilocaine hydrochloride by SEPTODONT INC on September 29^th, 2010.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CITANEST PLAIN?
What are the global sales for CITANEST PLAIN?
What is Average Wholesale Price for CITANEST PLAIN?

Summary for CITANEST PLAIN

US Patents:	0
Applicants:	2
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	101
Clinical Trials:	2
Patent Applications:	303
DailyMed Link:	CITANEST PLAIN at DailyMed

Drug patent expirations by year for CITANEST PLAIN

Recent Clinical Trials for CITANEST PLAIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Bozyaka Training and Research Hospital	Phase 4
Diskapi Teaching and Research Hospital	Phase 4

See all CITANEST PLAIN clinical trials

US Patents and Regulatory Information for CITANEST PLAIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Astrazeneca	CITANEST PLAIN	prilocaine hydrochloride	INJECTABLE;INJECTION	014763-007	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Dentsply Pharm	CITANEST PLAIN DENTAL	prilocaine hydrochloride	INJECTABLE;INJECTION	021382-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.